Home / Guides / Psychedelic trials recruiting in Europe
Guide · Europe · Clinical trials

Psychedelic trials recruiting in Europe (2026): psilocybin, MDMA, LSD and ketamine studies by country

Last updated · Registry statuses checked 19 November 2026 · Published by Psyche Vibes Ltd, London

The short answer. As of 19 November 2026, we list 27 psychedelic and ketamine-assisted therapy trials that public registries show as recruiting with at least one site in the UK or Europe. 16 of them test psilocybin or psilocin. The records come from ClinicalTrials.gov, the EU's CTIS register and ISRCTN (14 from ClinicalTrials.gov, 9 from EU CTIS, 4 from ISRCTN), and each links to its registry entry.

In the UK and most of Europe, a clinical trial is the main lawful way to receive these substances. Filter by country or substance below. The full data is in our directory.

Recruiting trials

Showing all 27 trials.

Recruiting trial

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Substance
Psilocybin
Condition
Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder
Sponsor
Cybin IRL Limited
Phase
Phase 3
European sites
Czechia, Germany, Greece, Ireland, Poland, United Kingdom (also: Australia, United States)
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06793397
Last checked
19 November 2026
Recruiting trial

PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm

Substance
Psilocybin
Condition
Self Harm
Sponsor
Imperial College London
Phase
Early phase 1
European sites
United Kingdom
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06798636
Last checked
19 November 2026
Recruiting trial

PsilOpioid: psilocybin therapy in opioid use disorder

Substance
Psilocybin
Condition
Opioid use disorder
Sponsor
Imperial College London (NIHR Imperial Clinical Research Facility)
European sites
United Kingdom
Status
Recruitment window open (ISRCTN)
Registry record
ISRCTN10232579
Last checked
19 November 2026
Recruiting trial

Sleep Blinding Psilocybin: feasibility study

Substance
Psilocybin
Condition
Depression
Sponsor
South London and Maudsley NHS Foundation Trust
European sites
United Kingdom
Status
Recruitment window open (ISRCTN)
Registry record
ISRCTN10648713
Last checked
19 November 2026
Recruiting trial

Ketamine for depression with anorexia nervosa (feasibility RCT)

Substance
Ketamine
Condition
Depression with anorexia nervosa
Sponsor
King's College London
European sites
United Kingdom
Status
Recruitment window open (ISRCTN)
Registry record
ISRCTN26462355
Last checked
19 November 2026
Recruiting trial

MORE-KARE: ketamine-assisted psychological therapy to reduce alcohol relapse

Substance
Ketamine
Condition
Severe alcohol use disorder
Sponsor
University of Exeter (multi-centre NHS sites)
European sites
United Kingdom
Status
Recruitment window open (ISRCTN)
Registry record
ISRCTN85955128
Last checked
19 November 2026
Recruiting trial

Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects

Substance
Psilocybin
Condition
Depression - Major Depressive Disorder, Anhedonia
Sponsor
Medical University of Vienna
Phase
Phase 1
European sites
Austria
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT07490353
Last checked
19 November 2026
Recruiting trial

Psilocybin Therapy for Psychological Distress in Palliative Patients

Substance
Psilocybin
Condition
COPD (Chronic Obstructive Pulmonary Disease), ALS (Amyotrophic Lateral Sclerosis), MS (Multiple Sclerosis)
Sponsor
University Medical Center Groningen
Phase
Phase 2
European sites
Czechia, Denmark, Netherlands, Portugal
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06782724
Last checked
19 November 2026
Recruiting trial

Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRAZ)

Substance
Psilocybin
Condition
Treatment-resistant depression
Sponsor
Groupe Hospitalier Universitaire Paris Psychiatrie & Neuroscience
European sites
France
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2024-512911-34-00
Last checked
19 November 2026
Recruiting trial

ERPPAD - Efficacy in Relapse Prevention: Psilocybin in Alcohol use disorder with Depressive symptoms

Substance
Psilocybin
Condition
Alcohol use disorder, depressive symptoms
Sponsor
Centre Hospitalier Universitaire De Nimes
European sites
France
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2025-525069-65-00
Last checked
19 November 2026
Recruiting trial

Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a pilot study

Substance
Psilocybin
Condition
Gambling disorder
Sponsor
Centre Hospitalier Universitaire De Nantes
European sites
France
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2025-522743-18-00
Last checked
19 November 2026
Recruiting trial

POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychological support for cocaine use disorder

Substance
Psilocybin
Condition
Cocaine addiction
Sponsor
Trinity College Dublin
European sites
Ireland
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2024-515147-32-02
Last checked
19 November 2026
Recruiting trial

Psilocybin versus Personalized Neuromodulation for Resistant Depression (PSILO-MODULATION)

Substance
Psilocybin
Condition
Treatment Resistant Depression (TRD)
Sponsor
Universita' Degli Studi G. D'Annunzio Di Chieti
European sites
Italy
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2024-519844-34-03
Last checked
19 November 2026
Recruiting trial

Trazodone’s Effects on Moderation of Psilocybin Outcomes (TEMPO)

Substance
Psilocybin
Condition
Treatment-Resistant Depression
Sponsor
Universita' Degli Studi G. D'Annunzio Di Chieti
European sites
Italy
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2025-523346-27-00
Last checked
19 November 2026
Recruiting trial

A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder

Substance
Psilocybin
Condition
Prolonged grief disorder
Sponsor
Linkopings Universitet
European sites
Sweden
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2024-518218-24-00
Last checked
19 November 2026
Recruiting trial

CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial

Substance
Psilocybin
Condition
Major Depressive Disorder, Malignant tumours ICD 10 C00 to C97
Sponsor
Region Stockholm – SLSO
European sites
Sweden
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2023-505532-35-00
Last checked
19 November 2026
Recruiting trial

Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa

Substance
Psilocybin
Condition
Anorexia Nervosa
Sponsor
Region Skane
Phase
Phase 2
European sites
Sweden
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT07169747
Last checked
19 November 2026
Recruiting trial

The therapeutic potential of psilocybin in anorexia nervosa in young adults

Substance
Psilocybin
Condition
Anorexia Nervosa
Sponsor
Region Skane
European sites
Sweden
Status
Ongoing, recruiting (EU CTIS)
Registry record
EU CTIS 2024-515163-63-00
Last checked
19 November 2026
Recruiting trial

LSD to Improve Cluster Headache Impact Trial

Substance
LSD
Condition
Chronic Cluster Headache
Sponsor
Radboud University Medical Center
Phase
Phase 2
European sites
Netherlands
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT05477459
Last checked
19 November 2026
Recruiting trial

LSD Treatment for Persons With Alcohol Use Disorder

Substance
LSD
Condition
Alcohol Use Disorder (AUD)
Sponsor
Felix Mueller
Phase
Phase 2
European sites
Switzerland
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT05474989
Last checked
19 November 2026
Recruiting trial

Lysergic Acid Diethylamide (LSD) in Palliative Care

Substance
LSD
Condition
Palliative Care, Pain, Anxiety
Sponsor
University Hospital, Basel, Switzerland
Phase
Phase 2
European sites
Switzerland
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT05883540
Last checked
19 November 2026
Recruiting trial

Antidepressant Response of DMT Masked With Propofol

Substance
DMT
Condition
Major Depressive Disorder, Psychedelic Experiences
Sponsor
University Hospital, Basel, Switzerland
European sites
Switzerland
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06927076
Last checked
19 November 2026
Recruiting trial

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

Substance
Ketamine
Condition
Obsessive-Compulsive Disorder, Psychiatric Disorder
Sponsor
Medical University of Vienna
European sites
Austria
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT05577585
Last checked
19 November 2026
Recruiting trial

Pharmacologic Treatment Augmentation in Chronic Depression

Substance
Ketamine
Condition
Major Depressive Disorder
Sponsor
University Hospital Tuebingen
Phase
Phase 2
European sites
Germany
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06410599
Last checked
19 November 2026
Recruiting trial

Ketamine Augmentation of ECT in Treatment-Resistant Depression

Substance
Ketamine
Condition
Major Depressive Disorder, Treatment Resistant Depression
Sponsor
Università Vita-Salute San Raffaele
Phase
Phase 3
European sites
Italy
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT07088380
Last checked
19 November 2026
Recruiting trial

Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients

Substance
Ketamine
Condition
Treatment Resistant Depression
Sponsor
Senz
European sites
Netherlands
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT07706478
Last checked
19 November 2026
Recruiting trial

Ketamine for Combined Depression and Alcohol Use Disorder

Substance
Ketamine
Condition
Depression, Alcohol Use Disorder
Sponsor
University Hospital of North Norway
Phase
Phase 1, Phase 2
European sites
Norway
Status
Recruiting (ClinicalTrials.gov)
Registry record
ClinicalTrials.gov NCT06090422
Last checked
19 November 2026

Trials by country

A trial with sites in several countries is counted once for each.

CountryRecruiting trials in our list
United Kingdom6
Austria2
Czechia2
Denmark1
France3
Germany2
Greece1
Ireland2
Italy3
Netherlands3
Norway1
Poland1
Portugal1
Sweden4
Switzerland3

How this list is made

Country guides: UK psilocybin trials · Germany · Czechia · Switzerland. Licensing status for each medicine is on the approval tracker.

Questions and answers

Are psilocybin trials recruiting in Europe?

Yes. As of 19 November 2026, our list has 16 psilocybin or psilocin trials that the registries show as recruiting with at least one site in the UK or Europe, out of 27 psychedelic and ketamine-assisted therapy trials in total.

Which European countries have psychedelic trials recruiting?

In our list as of 19 November 2026, the countries with the most recruiting trials are United Kingdom (6), Sweden (4), Netherlands (3), France (3), Italy (3). A multi-country trial counts once for each country with a listed site.

How do I take part in a psychedelic trial?

Open the registry record, check who can take part, and contact the study team listed there. Trials have strict eligibility rules and screening. Talk to your own doctor first, and do not stop any medication on your own.

Can I join a trial in another country?

Sometimes, but many trials only recruit people who live near a site and can attend every visit, and some only recruit through local health services. The registry record and the study team can tell you.

Why is a trial I know about missing?

We list only trials that a public registry shows as recruiting, with a site in the UK or Europe, and that test psychedelic-assisted or ketamine-assisted treatment in patients. We leave out pharmacology studies in healthy volunteers and records that look stale, for example where the registered end date has passed with no sign of recent activity. Email us if we have missed one.

Is this list complete?

No. It is a curated list that we check each week against ClinicalTrials.gov, the EU's CTIS register and ISRCTN. Use it as a starting point and check the registries directly.

Get UK and Europe access news each week

New trials, regulator decisions and law changes, with every claim linked to its source. Free, one email a week.

Subscribe free →

Sources

Each trial links to its own registry record, checked on the date shown on its card.

  1. ClinicalTrials.gov (US National Library of Medicine). https://clinicaltrials.gov/
  2. EU Clinical Trials Information System (CTIS): search for clinical trials. https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en
  3. ISRCTN registry. https://www.isrctn.com/